Petrovax begins dosing in Phase III trial of CanSino’s Covid-19 vaccine
Russia's Petrovax Pharm has started dosing participants in a Phase III clinical trial of Ad5-nCoV Covid-19 vaccine candidate developed by…
21 Sep 2020
BMS reports positive data of Opdivo in renal cell carcinoma trial
Bristol Myers Squibb (BMS) and Exelixis have reported that an Opdivo (nivolumab) and Cabometyx (cabozantinib) combination showed significant improvements across all efficacy endpoints in the Phase III CheckMate -9ER trial…
21 Sep 2020
Seattle Genetics-Astellas’ Padcev meets primary goal in urothelial cancer
Seattle Genetics and Astellas Pharma have reported that Padcev (enfortumab vedotin-ejfv) achieved its primary endpoint of overall survival in a Phase III clinical trial in adults with locally advanced or…
21 Sep 2020
Lynparza lowers death risk in Phase III prostate cancer trial
AstraZeneca and MSD (Merck) have reported that Lynparza (olaparib) reduced the risk of death by 31% in men with metastatic castration-resistant prostate cancer (mCRPC) in a Phase III PROfound clinical…
18 Sep 2020
Rigel launches Phase II trial to assess fostamatinib for Covid-19
Rigel Pharmaceuticals has launched a Phase II clinical trial to test the safety of fostamatinib to treat hospitalised Covid-19 patients. The study is funded by the National Heart, Lung, and…
18 Sep 2020
Roche’s Actemra reduces need for mechanised ventilation in Covid-19 patients
Roche has reported that its Actemra/RoActemra (tocilizumab) reduced the need for mechanical ventilation in hospitalised Covid-19 patients with associated pneumonia in the Phase III EMPACTA clinical trial. The trial met…
18 Sep 2020
Atossa Therapeutics reports positive safety data of Covid-19 drug
Atossa Therapeutics has reported positive interim safety data from the second cohort of participants in a Phase I clinical trial of its Covid-19 drug candidate, AT-301, given as nasal spray.…